XU CHERYL 4
4 · 60 DEGREES PHARMACEUTICALS, INC. · Filed Jun 5, 2025
Insider Transaction Report
Form 4
XU CHERYL
Director
Transactions
- Purchase
Common Stock
2025-06-03$2.87/sh+3,000$8,610→ 13,816 total - Purchase
Common Stock
2025-06-03$2.90/sh+2,000$5,800→ 15,816 total
Footnotes (1)
- [F1]Reflects a 1-for-5 reverse stock split effective February 24, 2025, resulting in the reporting person's beneficial ownership being adjusted from 54,078 shares to 10,816 shares. Fractional shares were rounded up to the nearest whole share